Tampa biotech firm elevates board member to president, CEO

Kimberly Murphy is the new leader of Oragenics, which is producing a nasal vaccine to fight COVID-19.

  • By Business Observer Staff
  • | 12:33 p.m. June 24, 2022
Kimberly Murphy is the new president and CEO of Tampa biotech firm Oragenics. (Courtesy photo)
Kimberly Murphy is the new president and CEO of Tampa biotech firm Oragenics. (Courtesy photo)
  • Tampa Bay-Lakeland
  • Share

Oragenics Inc. (NYSE: OGEN), a Tampa-based biotech company that focuses on treatments for infectious diseases, including COVID-19, has named Kimberly Murphy president and CEO.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • March 31, 2026
South Seas buys 22-acre artist retreat on Captiva
  • March 31, 2026
Pizzeria closes on Main Street in Sarasota
  • March 31, 2026
Naples man faces decades in prison for cheating elderly woman
  • March 31, 2026
Southwest Florida construction firm opens Tampa office

Sponsored Content